|Articles|May 2, 2019

eyeforpharma Awards 2019 Announced

eyeforpharma announced the date for their awards event for 2019. The eyeforpharma awards focus exclusively on value for patients and HCPs to support the best work in the industry.

The awards will be celebrating health entrepreneurs, valuable collaborations, patient advocates, and champions. The patient awards will be judged by a group of patients for the patients. The nominations are now open for the 13 categories, and the ceremony will take place on December 11th in Philadelphia.

Nominations open 29th April, closing 9th August, with Finalists announced by eyeforpharma on 5th September. Finalists will be selected by a judging panel of industry experts.

For more information, visit here or contact Liz Swift at eswift@eyeforpharma.com.

 

 


Related to this article

Pharmaceutical Executive Daily
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.